Miao Yu

Direktor/Vorstandsmitglied bei

MicuRx Pharmaceuticals, Inc.

38 Jahre

Consumer Services

Health Technology

Profil

Miao Yu is currently a Non-Executive Director at MicuRx Pharmaceuticals, Inc. and an Executive Director at GP Healthcare Capital Co., Ltd. Previously, Mr. Yu worked as a Director at Adagene, Inc. from 2020 to 2021.
Mr. Yu holds a graduate degree from Northeastern University and an undergraduate degree from China Pharmaceutical University.

Aktive Positionen von Miao Yu

Unternehmen	Position	Beginn
MicuRx Pharmaceuticals, Inc. MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug resistant bacterial infections	Direktor/Vorstandsmitglied	30.08.2016
GP Healthcare Capital Co. , Ltd. GP Healthcare Capital Co. , Ltd. Part of GP Capital Co. Ltd., GP Healthcare Capital Co., Ltd. is a Chinese investment fund management company with a focus on the healthcare service industry and broader industrial and equity investments. The company is based in SH. Established in 2009, it manages large-scale funds such as the Shanghai Financial Development Investment Fund, supported by the Shanghai municipal government and major institutional investors. GP Healthcare Capital specializes in initiating, managing, and operating investment funds with a professional, market-oriented, and international approach. Its senior management team includes professionals from securities regulation, national industrial funds, and investment banks. The company operates subsidiary fund management companies across various sectors. A key branch, Shanghai GP Healthcare Capital Co., Ltd., founded in 2015, focuses on investment, mergers, and integration within the healthcare sector, managing funds and partnering with government guidance funds, asset managers, and healthcare enterprises.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Miao Yu

Ehemalige bekannte Positionen von Miao Yu

Unternehmen	Position	Ende
ADAGENE INC.	Direktor/Vorstandsmitglied	26.08.2021

Sehen Sie sich die Erfahrung von Miao Yu im Detail an

Ausbildung von Miao Yu

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Miao Yu im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
Northeastern University Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
MicuRx Pharmaceuticals, Inc. MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug resistant bacterial infections	Health Technology
China Pharmaceutical University China Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Adagene, Inc. Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies	Health Technology
GP Healthcare Capital Co. , Ltd. GP Healthcare Capital Co. , Ltd. Part of GP Capital Co. Ltd., GP Healthcare Capital Co., Ltd. is a Chinese investment fund management company with a focus on the healthcare service industry and broader industrial and equity investments. The company is based in SH. Established in 2009, it manages large-scale funds such as the Shanghai Financial Development Investment Fund, supported by the Shanghai municipal government and major institutional investors. GP Healthcare Capital specializes in initiating, managing, and operating investment funds with a professional, market-oriented, and international approach. Its senior management team includes professionals from securities regulation, national industrial funds, and investment banks. The company operates subsidiary fund management companies across various sectors. A key branch, Shanghai GP Healthcare Capital Co., Ltd., founded in 2015, focuses on investment, mergers, and integration within the healthcare sector, managing funds and partnering with government guidance funds, asset managers, and healthcare enterprises.